We are live on ! Find out more
BIOSW

BioPlus Acquisition Corp. Warrants
BIOSW

Delisted

BIOSW was delisted on the 6th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in BioPlus Acquisition Corp. Warrants in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 46 → 0 (-46)

100% less capital invested

Capital invested by funds: $560K → $0 (-$560K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 46

Holders
–
Holders Change
-46
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
46
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SCM
Saba Capital Management
New York
-$52.7K
2
PC
Periscope Capital
Ontario, Canada
-$48.6K
3
LA
Linden Advisors
New York
-$34.9K
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$33.7K
5
CAC
Cowen and Company
New York
-$29.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
PC
1
Periscope Capital
Ontario, Canada
– -$48.6K -867,072 Closed
SCM
2
Saba Capital Management
New York
– -$52.7K -756,253 Closed
PAMP
3
Polar Asset Management Partners
Ontario, Canada
– -$33.7K -601,932 Closed
SCM
4
Shaolin Capital Management
Florida
– -$29K -525,001 Closed
CAC
5
Cowen and Company
New York
– -$29.2K -522,096 Closed
Calamos Advisors
6
Calamos Advisors
Illinois
– -$28K -500,000 Closed
LA
7
Linden Advisors
New York
– -$34.9K -500,000 Closed
Goldman Sachs
8
Goldman Sachs
New York
– -$23.1K -412,547 Closed
MI
9
MMCAP International
Cayman Islands
– -$18.2K -325,000 Closed
AA
10
AQR Arbitrage
Connecticut
– -$16.5K -294,525 Closed
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
– -$15.3K -272,750 Closed
CSS
12
Cubist Systematic Strategies
Connecticut
– -$14.1K -251,483 Closed
CF
13
Cantor Fitzgerald
New York
– -$14K -250,000 Closed
DKCM
14
Davidson Kempner Capital Management
New York
– -$14K -250,000 Closed
TCA
15
Taconic Capital Advisors
New York
– -$14K -250,000 Closed
SC
16
Sculptor Capital
New York
– -$16.8K -241,700 Closed
KL
17
KIM LLC
Kansas
– -$12.3K -219,800 Closed
RCM
18
Radcliffe Capital Management
Pennsylvania
– -$13.9K -200,049 Closed
HIM
19
HGC Investment Management
Ontario, Canada
– -$11.2K -200,000 Closed
QGA
20
Q Global Advisors
Texas
– -$11K -195,489 Closed
UOC
21
UBS O'Connor
Illinois
– -$12.7K -182,071 Closed
Walleye Capital
22
Walleye Capital
New York
– -$9.85K -175,889 Closed
CS
23
Clear Street
New York
– -$7.76K -138,610 Closed
EFI
24
EHP Funds Inc
Canada
– -$7.01K -125,186 Closed
ACM
25
Atalaya Capital Management
New York
– -$7.5K -125,000 Closed
1
2

BIOSW Hedge Fund Activity: Q4 2023 in Review

0 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in BioPlus Acquisition Corp. Warrants (BIOSW) for Q4 2023, worth a combined $0 — down 100% from $560K a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of BIOSW and 0 opened new positions — a net loss of 46 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Saba Capital Management, exiting entirely with an estimated $52.7K sold.

  • 0 institutional investors held BioPlus Acquisition Corp. Warrants (BIOSW) as of Q4 2023, down from 46 in Q3 2023.
  • Funds reported $0 of BioPlus Acquisition Corp. Warrants stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new BioPlus Acquisition Corp. Warrants positions in Q4 2023 and 46 closed out, a net change of -46 holders.
  • The largest BioPlus Acquisition Corp. Warrants seller in Q4 2023 was Saba Capital Management, an estimated $52.7K sold.

Based on aggregated 13F filings for Q4 2023.